Showing results (131-140 of 175) with videos related to
Sort By:
Pageof 18
Diabetes Care|October 23, 2013
Nonlaboratory-based risk assessment algorithm for undiagnosed type 2 diabetes developed on a nation-wide diabetes surveyXianghai Zhou, Qing Qiao, Linong Ji, et al.Diabetes, Obesity & Metabolism|April 3, 2019
Determining the optimal fasting glucose target for patients with type 2 diabetes: Results of the multicentre, open-label, randomized-controlled FPG GOAL trialWenying Yang, Jianhua Ma, Guoyue Yuan, et al.The Journal of Biological Chemistry|July 5, 2022
Exploring high-resolution chromatin interaction changes and functional enhancers of myogenic marker genes during myogenic differentiationKeren Long, Xiaokai Li, Duo Su, et al.Journal of Diabetes|April 25, 2020
Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT)Leili Gao, Puhong Zhang, Jianping Weng, et al.Communications Medicine|February 22, 2023
Higher mitochondrial DNA copy number is associated with metformin-induced weight lossJing Wang, Hua Liang, Rong Huang, et al.Diabetes, Obesity & Metabolism|January 21, 2017
Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real-life use of basal insulin in ChinaLinong Ji, Puhong Zhang, Dongshan Zhu, et al.Diabetes Care|July 15, 2016
Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention StudyQiuhong Gong, Ping Zhang, Jinping Wang, et al.Diabetes Technology & Therapeutics|July 15, 2015
Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China--Study Design and Baseline CharacteristicsLinong Ji, Puhong Zhang, Jianping Weng, et al.Diabetes Care|April 19, 2015
Cardiovascular and All-Cause Mortality Over a 23-Year Period Among Chinese With Newly Diagnosed Diabetes in the Da Qing IGT and Diabetes StudyYali An, Ping Zhang, Jinping Wang, et al.The Lancet. Diabetes & Endocrinology|April 16, 2014
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up studyGuangwei Li, Ping Zhang, Jinping Wang, et al.Pageof 18